---
title: "Morning Trend | GRANDPHARMA consolidates with reduced volume, can the key support hold?"
description: "On December 17th, GRANDPHARMA (512.HK) continued to consolidate weakly, with low trading activity throughout the day and funds remaining cautious. The significant fluctuations during the session lacke"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/269980748.md"
published_at: "2025-12-18T01:00:00.000Z"
---

# Morning Trend | GRANDPHARMA consolidates with reduced volume, can the key support hold?

> On December 17th, GRANDPHARMA (512.HK) continued to consolidate weakly, with low trading activity throughout the day and funds remaining cautious. The significant fluctuations during the session lacked strong participation from major players, the MACD death cross remains unresolved, and the moving average system is entirely bearish. The short-term market relies on support at the 5.06 yuan level. There is a scarcity of excitement in the industry sector, with slow progress in new drug approvals and policy changes. Although there were news about local access for innovative drugs this week, the details have not been finalized, and the enthusiasm for fund participation has not been ignited. The leading stocks in the sector continue to observe, and small-cap stocks see quick rises during the session followed by profit-taking. Key attention should be paid to the gains and losses of support levels and changes in intraday volume; a simultaneous rise in volume and price is a necessary condition for a rebound. The overall market lacks a leading trend, and short-term focus should be on unusual movements by major players and marginal policy events. If no substantial signals are observed, it is recommended that investors remain cautious, avoid chasing prices, and steer clear of the risk of secondary declines caused by breaking support

On December 17th, GRANDPHARMA (512.HK) continued to consolidate weakly, with low trading activity throughout the day and funds remaining cautious. The significant fluctuations during the session lacked strong participation from major players, the MACD death cross remains unresolved, and the moving average system is entirely bearish. The short-term market relies on support at the 5.06 yuan level.

There is a scarcity of excitement in the industry sector, with slow progress in new drug approvals and policy changes. Although there were news of local access for innovative drugs this week, the details have not been finalized, and the enthusiasm for fund participation has not been ignited. The leading stocks in the sector continue to observe, and after a quick rise in small-cap stocks during the session, profit-taking was observed.

Key attention should be paid to the gains and losses of support levels and changes in intraday volume. A simultaneous increase in volume and price is a necessary condition for a rebound. The overall market lacks a leading bullish trend, and short-term focus should be on unusual movements by major players and marginal policy events. If no substantial signals are observed, it is recommended that investors remain cautious, avoid chasing prices, and steer clear of the risk of a secondary decline due to the loss of support

### Related Stocks

- [00512.HK - GRANDPHARMA](https://longbridge.com/en/quote/00512.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 雷軍：未來五年小米將重點攻堅芯片、AI、操作系統等底層核心技術 | 小米集團董事長兼 CEO 雷軍在民營企業座談會上表示，未來五年小米將重點攻堅芯片、AI、操作系統等底層核心技術。他強調，民營經濟促進法的實施為企業提供了更好的營商環境，支持政策更加精準。雷軍指出，民營企業應與國家發展戰略同頻共振，專注於創新 | [Link](https://longbridge.com/en/news/276701602.md) |
| 春節消費數據：春運創歷史最多出行人次，國內遊熱度提升，電影票房弱於往年 | 東吳證券指出，今年春節期間出行人次創歷史新高，國內旅遊熱度上升，而出境遊熱度下降。春節假期國內航班數量較去年增長，反映出國內遊的提升。電影票房表現不佳，春節檔票房累計僅 43.6 億元，低於往年平均水平。預計全年消費將受到更多政策支持，政策 | [Link](https://longbridge.com/en/news/276592177.md) |
| 期權交易員加碼做空軟件公司貸款 ETF，規模創 2023 年來新高 | 受困於 18% 的軟件業貸款敞口，Invesco 優先貸款 ETF 遭遇猛烈做空，看跌期權合約飆升至 40 萬份，未平倉量創 2023 年來新高。與此同時，該基金連續四周流出近 10 億美元，投資者更是大舉平倉軟件股指 ETF 的看漲期權。 | [Link](https://longbridge.com/en/news/276668151.md) |
| 港股異動速遞：奧威控股大跌 20%，MINIMAX-WP 跌超 15%，怡俊集團逆勢漲 15% | 港股近一小時市場概況市場情緒似乎出現了明顯的分化，整體盤面波動幅度加大，資金流向集中在個別股票上。小盤股和題材股的表現較為活躍，而一些傳統行業則顯得相對疲軟。短線熱度變化明顯，部分資金在高位獲利了結，導致個別股票出現較大跌幅。整體來看，市場 | [Link](https://longbridge.com/en/news/276852333.md) |
| “全市場的希望”！美股科技股陷入 2022 年來最糟開局，英偉達業績成扭轉頹勢關鍵 | 美股科技股創 2022 年以來最差開局，軟件板塊因 AI 顛覆擔憂重挫 23%。儘管能源等板塊補位支撐大盤橫盤，但科技股 33% 的高權重仍是上行枷鎖。市場正屏息等待英偉達週三財報，其業績與指引將成為驗證 “AI 投資回報” 的關鍵支點，決 | [Link](https://longbridge.com/en/news/276893311.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.